• Bio-IT World News Briefs: April

    Apr 27, 2012, 02:00 AM by Michael Croft
    Bio-IT World | Bio-IT World’s 10th Anniversary Conference and Expo wrapped up yesterday in Boston. With a record-breaking more than 2,500 attendees, the event was packed with great speakers and events. Here’s a roundup of some of the announcements and stories to come out of the event and elsewhere over the past month. 
    Full story

  • Open Source Health Data Repository Launched

    Apr 27, 2012, 02:00 AM by Michael Croft
    Nature | A project based in Kansas City, Missouri, aims to create the world's largest pool of open data about health and genomics. The data themselves will come from a variety of sources including consumer-reported direct-to-consumer genomic testing results.
    Full story

  • Heng Li Credits Durbin Pedigree in Accepting Franklin Award

    Apr 26, 2012, 14:40 PM by Michael Croft
    Bio-IT World | The Broad Institute's Heng Li became the fourth former member of the Richard Durbin lab at the Wellcome Trust Sanger Institute to win the Benjamin Franklin Award for bioinformatics, presented this week at the Bio-IT World Expo.  
    Full story

  • 2012 Best of Show Winners

    Apr 26, 2012, 10:00 AM by Michael Croft
    Bio-IT World | Bio-IT World announced the winners of the Best of Show competition yesterday evening at the 2012 Bio-IT World Conference & Expo in Boston. Recentris, Opscode, Clear Trial, and Cambridge Semantics were honored. 
    Full story

  • Illumina Announces Basespace Genomic App Store

    Apr 26, 2012, 01:00 AM by Michael Croft
    Xconomy | Illumina announced an open platform for genomic apps at the Bio-IT World Conference & Expo yesterday. Basespace Apps will use the Amazon cloud and let users download various genomic software options. 
    Full story

  • Hello Siri, Please Start My Experiment Now

    Apr 25, 2012, 15:05 PM by Michael Croft
    Bio-IT World | BOSTON -- BT Global Services showed the first use of Siri, the Apple iPhone’s voice-activated natural language processing technology, to launch, run and deliver the results of an experiment in the newly announced BT Cloud today at the Bio-IT World Expo. 
    Full story

  • Bio-It World Announces Winners of 2012 Best Practices Awards

    Apr 25, 2012, 07:30 AM by Michael Croft
    Bio-IT World | BOSTON—Bio-IT World announced the winners of its eighth Best Practices Awards competition this morning in a plenary session at the 2012 Bio-IT World Conference & Expo in Boston. Grand Prize winners from five life sciences awards categories included entries from three big pharma companies—Merck, Pfizer, and Merck KGaA (Germany)—and two genomics organizations, BGI Shenzhen and the University of Utah/Omicia. 
    Full story

  • Lombardi Lays Out His Vision for Real Time Genomics

    Apr 25, 2012, 06:10 AM by Michael Croft
    Bio-IT World | BOSTON—Less than two weeks into his new position as CEO of Real Time Genomics (RTG), Steve Lombardi shared some of his early vision with Bio-IT World, judging this week’s conference to be the perfect venue to make the official announcement. 
    Full story

  • 10,000 Names In, What the Boycott Means for Elsevier, Open Access

    Apr 25, 2012, 05:00 AM by Michael Croft
    The Guardian | With more than 10,000 scientists pledging to boycott Elsevier on the Cost of Knowledge website, the site's creator, Tyler Neylon, talks about open access and what will come next for scientific publishing.
    Full story

  • Twitter Highlights from Bio-IT World Keynotes

    Apr 25, 2012, 00:00 AM by Michael Croft
    Bio-IT World | The 10th Anniversary of the Bio-IT World Conference and Expo kicked off yesterday evening. With over 2,500 registered attendees, the anniversary event is already proving to be a record breaker. Opening keynote presentations by Jill P. Mesirov, Associate Director and Chief Informatics Officer; Director, Computational Biology and Bioinformatics and Martin Leach, CIO, both of the Broad Institute of MIT and Harvard were chronicled by hundreds of tweets.
    Full story

  • Amazon Announces Asia Pac Beanstalk Expansion, Rumors of Data Centers in Sydney, Hong Kong

    Apr 24, 2012, 00:45 AM by Michael Croft
    Roundup | Amazon is expanding the availabilty of the AWS Elastic Beanstalk to Japan, making the service available to developers in the US East and now Asia Pacific regions, and Amazon's newest data centers are rumored to be in the works for Sydney and Hong Kong.
    Full story

  • 454, MiSeq, and PGM Go Head to Head

    Apr 23, 2012, 04:30 AM by Michael Croft
    Nature | A group of UK-based researchers compare the newest breed of sequencers: Roche’s 454 GS Junior, Illumina’s MiSeq and Life Technologies’ Ion Torrent Personal Genome Machine (PGM). 
    Full story

  • The Foundation Approach to Drug Discovery

    Apr 23, 2012, 04:00 AM by Michael Croft
    The Atlantic | There's been much debate about the best drug discovery business model, with the weaknesses of both academia and pharma made painfully clear. But perhaps the best business model is being practiced by translation-focused disease foundations. 
    Full story

  • Human Genome Sciences Rejects GSK Offer

    Apr 20, 2012, 00:10 AM by Michael Croft
    Bloomberg BusinessWeek | In a second buyout rejection this week, Human Genome Sciences rejected a $2.59 billion acquisition bid from GlaxoSmithKline. The two companies currently partner on a lupus treatment. 
    Full story

  • Going Up: Cycle Launches 50,000-Core Utility Supercomputer in the Cloud

    Apr 19, 2012, 08:15 AM by Michael Croft
    Bio-IT World | In the latest in a string of cloud computing firsts, Cycle Computing has collaborated with Schrödinger and Nimbus Discovery to spin up a 50,000-core supercomputer in the Amazon Web Services (AWS) cloud. 
    Full story

  • GSK Signs $30m Deal for Asthma, COPD Drugs

    Apr 19, 2012, 03:00 AM by Michael Croft
    San Francisco Business Times | GlaxoSmithKline has signed a second collaboration with Five Prime Therapeutics to develop drugs for asthma and COPD. Five Prime is eligible to receive payments up to $30 million over the next four years.
    Full story

  • Illumina Holds On to Board of Directors, Company

    Apr 19, 2012, 02:30 AM by Michael Croft
    DealBook | Roche walked away from the table yesterday after Illumina shareholders voted to re-elect all of Illumina's directors by a large margin. On Wednesday, Illumina shares closed at $44.51, one cent higher than Roche's inital bid.
    Full story

  • Decision Day for Illumina, Roche

    Apr 18, 2012, 02:10 AM by Michael Croft
    Roundup | Today is Illumina's board meeting, and there is much theorizing about the outcome. After two rejected bids, Roche has nominated six directors and proposed expanding the Illumina board to 11 members. Illumina--along with two independent advisory firms--has recommended that shareholders vote for the four Illumina nominees.
    Full story

  • Wingu Announces Google Funding

    Apr 18, 2012, 00:05 AM by Michael Croft
    Digital Journal | Wingu, a developer of software designed to enhance the operational efficiency of pharmaceutical research and discovery, announced a Series A round of funding led by Google Ventures with additional investment from Borealis Ventures. 
    Full story

  • DecisionView’s Consortium Approach to Optimizing Enrollment

    Apr 17, 2012, 04:10 AM by Michael Croft
    eCliniqua | For industry leader Merck, country-specific and site-level performance metrics have been among the early wins from the DecisionView Enrollment Benchmarks data set, says Brendan O’Neill, Merck’s director and head of global trial optimization. The pharmaceutical giant last June joined peers GlaxoSmithKline and Roche in working with DecisionView to turn their combined operational patient enrollment data into a cross-industry set of clinical trial enrollment benchmarks. 
    Full story